The company's investigational GLP-1 treatment performed admirably well in a phase 2b study.

Structure's aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech's stock up nearly 103% as ...

Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...

The more researchers examine RNA, the more surprises they continue to uncover. What have we learned about RNA structure and function so far? Although RNA is a single-stranded molecule, researchers ...

There has been a plethora of experimental approaches that combine traditional chemical probing techniques with next-generation sequencing. These methods have allowed the first glimpse of the 'RNA ...

Picture the most successful companies in the world; they have one thing in common — an effective organizational structure. But what exactly does that entail and how can it make or break a business? If ...